US Patent

US11583542 — Compositions of bile acids and phenylbutyrate compounds

Formulation · Assigned to Amylyx Pharmaceuticals Inc · Expires 2040-07-27 · 14y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects compositions that include a phenylbutyrate compound and a bile acid, and methods for processing these compositions.

USPTO Abstract

The present disclosure relates to compositions including a phenylbutyrate compound and a bile acid, and methods of processing such compositions.

Drugs covered by this patent

sodium-phenylbutyrate (SODIUM PHENYLBUTYRATE)

Patent Metadata

Patent number: US11583542
Jurisdiction: US
Classification: Formulation
Expires: 2040-07-27
Drug substance claim: No
Drug product claim: Yes
Assignee: Amylyx Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.